- Peter SEBO, Professor at the Academy of Sciences Of Czech Republic (ASCR)
Professor Peter SEBO is the founder of the Institute of Biotechnology of the ASCR, Czech Academy of Sciences, Prague, Czech Republic. Peter currently heads the laboratory of Molecular Biology and Pathogenic Bacteria. Peter is internationally recognized as the world expert of in host-pathogen interactions and bacterial protein toxins. In 2005, he was bestowed with the « Chevalier des palmes académqiues » award by the French Prime Minister. Peter is elected to the European Academy of Microbiology and is a member of the EMBO.
Peter is the author of 110 peer-reviewed scientific publications and 7 international patents. Peter is an expert in CyaA and related mechanism of actions.
- Claude LECLERC, Professor at the Institut Pasteur of Paris
Claude Leclerc is a professor at the Institut Pasteur where she heads a joint INSERM / Pasteur Immune Regulation and Vaccinology unit. Claude has concentrated her research interest in vaccinology and in particular on the development of new vaccination strategies, based on our knowledge of how immune responses are induced and regulated. It has contributed to the development of synthetic adjuvants, synthetic peptide vaccines and several delivery systems, to deliver antigens to dendritic cells. Claude is the pioneer in the development of vector based on the adenylate cyclase (CyaA). Her team developed three therapeutic vaccines (cancer) under clinical development.
Claude is the author of more than 300 publications in renowned scientific journals and patents.
Claude Leclerc chairs the Scientific Advisory Board of the Cochin-Pasteur Clinical Investigation Center in Vaccinology and was Vice-President of the Scientific Council of the Institut Pasteur and a member of the Board of Directors of the Institut Pasteur.
- Alain BOSQUET-MELOU, Professor at the National Veterinary School of Toulouse (ENVT)
Alain Bousquet-Melou is Professor of Therapeutic Pharmacology at the National Veterinary School of Toulouse (ENVT). He leads the Pharmacokinetics Pharmacodynamics & Modeling team within the TOXALIM platform. He is a member of the Scientific Council of the ENVT and a veterinary expert at the ANSES as a member of the Committee of Specialized Experts (CES) "Veterinary Medicine". Alain is the author of more than 60 publications in renowned scientific journals